Paxman
36.5 SEK +3.11%Be the first to follow this company
Paxman is active in scalp cooling, which is used for patients being treated for chemotherapy. The company's product Paxman Scalp Cooler is used to minimize the patient's hair loss during treatment. The Scalp Cooler is a stand-alone, mobile, and electrically powered cooling unit that cools the patient's scalp via a cooling cap. The company was founded in 1996 and has its headquarter in Karlshamn.
Revenue
210.12M
EBIT %
6.01 %
P/E
82.95
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PAX
Daily low / high price
34.6 / 38.7
SEK
Market cap
693.96M SEK
Turnover
2.15M SEK
Volume
59K
Financial calendar
General meeting
2024-05-23
Interim report
2024-05-23
Interim report
2024-08-21
Interim report
2024-11-15
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Glenn Paxman | 30.8 % | 30.8 % |
Försäkringsaktiebolaget Avanza Pension | 11.5 % | 11.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Paxman publishes the company’s annual report for 2023
KALLELSE TILL ÅRSSTÄMMA I PAXMAN AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools